Andrew Chase
- Hematology top 0.1%
- Chronic Myeloid Leukemia Treatments 65
- Acute Myeloid Leukemia Research 37
- Hematopoietic Stem Cell Transplantation 10
- Genetics top 0.2%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 34
- Chronic Lymphocytic Leukemia Research 22
- Rheumatology top 0.5%
- Eosinophilic Disorders and Syndromes 37
- Molecular Biology top 2%
- Epigenetics and DNA Methylation 6
- Cancer Research top 5%
-
- Acute Lymphoblastic Leukemia research 7
- Co-authors
- Nicholas C.P. CrossFrancis GrandJohn M. GoldmanAndreas ReiterDavid OscierAmy V. JonesKaterina ZoiJ Bungey
- Cited by
- HematologyGeneticsRheumatology
- Journals
- Blood (27 papers)Genes Chromosomes and Cancer (12 papers)British Journal of Haematology (10 papers)
- Partner nations
- United KingdomGermanyUnited States
In The Last Decade
Andrew Chase
99 papers receiving 5.7k citations
Hit Papers
Peers
Comparison fields: 5 of 105
- Hematology 3.5k
- Genetics 2.5k
- Rheumatology 1.5k
- Molecular Biology 2.7k
- Cancer Research 429
Countries citing papers authored by Andrew Chase
This map shows the geographic impact of Andrew Chase's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Chase with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Chase more than expected).
Fields of papers citing papers by Andrew Chase
This network shows the impact of papers produced by Andrew Chase. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Chase. The network helps show where Andrew Chase may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Andrew Chase, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2023 | 1 | |
| 4 | 2020 | 10 | |
| 5 | 2012 | 30 | |
| 6 | 2010 | 46 | |
| 7 | 2010 | 25 | |
| 8 | 2009 | 56 | |
| 9 | 2009 | 6 | |
| 10 | 2007 | 39 | |
| 11 | 2003 | 1 | |
| 12 | 2002 | 52 | |
| 13 | 2002 | 46 | |
| 14 | 1999 | 7 | |
| 15 | 1999 | 6 | |
| 16 | 1999 | 21 | |
| 17 | 1998 | 22 | |
| 18 | 1998 | 29 | |
| 19 | 1997 | 43 | |
| 20 | 1993 | 22 |
About Andrew Chase
Andrew Chase is a scholar working on Hematology, Genetics, Rheumatology, Immunology and Pathology and Forensic Medicine, having authored 103 papers that have together received 5.9k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (65 papers), Acute Myeloid Leukemia Research (37 papers), Eosinophilic Disorders and Syndromes (37 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (34 papers), Chronic Lymphocytic Leukemia Research (22 papers), Hematopoietic Stem Cell Transplantation (10 papers), Acute Lymphoblastic Leukemia research (7 papers) and Epigenetics and DNA Methylation (6 papers). The work is most often cited by research in Hematology (3.5k citations), Genetics (2.5k citations), Rheumatology (1.5k citations), Molecular Biology (2.7k citations) and Cancer Research (429 citations). Andrew Chase has collaborated with scholars based in United Kingdom, Germany and United States. Frequent co-authors include Nicholas C.P. Cross, Francis Grand, John M. Goldman, Andreas Reiter, David Oscier, Amy V. Jones, Katerina Zoi, J Bungey, Thomas Ernst and Claire Hidalgo-Curtis. Their work appears in journals such as Blood, Genes Chromosomes and Cancer, British Journal of Haematology, Leukemia and Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.